Le Lézard
Classified in: Covid-19 virus
Subjects: MAV, PSF, CFG

/R E P E A T -- Media Advisory - Minister Blair to make an announcement regarding the Security Infrastructure Program/


OTTAWA, ON, July 20, 2021 /CNW/ - Members of the media are invited to join the Honourable Bill Blair, Minister of Public Safety and Emergency Preparedness, for an announcement on the results of the last Call for Applications for the Communities at Risk: Security Infrastructure Program (SIP).

He will be joined by the Honourable Mary Ng, Minister of Small Business, Export Promotion and International Trade.

Following the announcement, Ministers Blair and Ng will take questions from the media.

This event will also be live-streamed via Twitter. Follow-us at @Safety_Canada.

Date
Wednesday, July 21, 2021

Time
9:30 a.m. EDT

Location
Chabad Lubavitch of Markham
83 Green Lane
Thornhill, Ontario

Media representatives who wish to attend the event must arrive at least 15 minutes in advance to sign in and present photo ID and credentials.

Media who wish to participate by phone can dial-in by using the numbers below. Media are encouraged to dial-in 15 minutes before the start of the news conference. Teleconference participants will be able to ask questions.

Participant dial-in numbers: 613-954-9003 / 1-866-206-0153
Access Code: 3000963#

Media and guests are asked to respect local physical distancing guidelines. Participants will be required to share their name and phone number for possible contact tracing. Wearing masks is recommended, especially when not able to maintain physical distance.

Public health protocols are in effect: please stay home if you are experiencing any of the symptoms listed here: About Coronavirus (COVID-19) | Public Health Ontario, practice good hand washing and other hygiene steps, as well as physical distancing.

SOURCE Public Safety and Emergency Preparedness Canada


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: